Comparison of intermediate outcome of transcatheter vs. surgical pulmonary replacement What did we learn?

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20211025003

Enrollment

210

Registered

2021-10-25

Start date

2020-09-09

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post surgical repair of Tetralogy of Fallot patients with severe pulmonary regurgitation and need pulmoary valve replacment. fallot tetralogy

Interventions

Transcatheter ,Surgery

Treatment,Treatment

Transcatheter pulmonary valve replacment ,Surgical pulmonary valve replacment

Eligibility

Sex/Gender

All

Age

12 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients that underwent TPVR or SPVR for RVOT dysfunction (both native and conduit) in Siriraj hospital between 2010 and 2021.

Exclusion criteria

Exclusion criteria: Patients who did have PVR successfully implanted.

Design outcomes

Primary

Measure	Time frame
successful implantati%on 2 years follow up PV landing zone (mm)	—

Secondary

Measure	Time frame
dead or alive up to 90 days Post PVR dead or alive	—

Countries

Thailand

Contacts

Public ContactKritvikrom Durongpisitkul

Faculty of Medicine Siriraj Hospital, Mahidol University

kritvikrom.dur@mahidol.ac.th66819875334

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026